MASH typically develops in individuals with obesity, insulin resistance, and metabolic syndrome
GLP-1 medications currently named in lawsuits and regulatory investigations include: Individuals who experienced hospitalization, emergency treatment, surgery, prolonged gastrointestinal symptoms, or medically documented vision loss after taking these medications may have grounds to pursue legal action
Compliance with Ethics Guidelines Approval by an ethics committee was not required for this study because only de-identified secondary data were used
Certified medical environments help maximize benefits while minimizing complications, making professional supervision one of the most important factors in achieving safe and effective results
22,23 While the topical use of forskolin appears promising, at least in animals and humans, 24 clinical studies of its use in glaucoma patients are lacking
Postmenopausal women and elderly women may be at greatest risk